Pricing and reimbursement of novel oncology drugs in Sweden.

J Mark Access Health Policy · 2014 · PMC4865793 · PMID 27226841

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Furthermore, regional disparities within Europe are likely to be significant, contributing to the previously reported heterogeneous uptake across different countries ( 2 ).

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.